884
Views
14
CrossRef citations to date
0
Altmetric
Letter to the Editor

Hawaii natural compounds are promising to reduce ovarian cancer deaths

, &
Pages 709-712 | Received 06 Apr 2016, Accepted 08 Apr 2016, Published online: 27 May 2016

References

  • Daftary S, Chakravarti S. Manual of Obstetrics. 2011; 3rd Edition. Elsevier: pp. 1–16
  • Gondos B. Classification of tumors of the ovary: developmental and ultrastructural considerations. Ann Clin Lab Sci 1979; 9:179-88; PMID:464540
  • Colombo N, Peiretti M, Parma G, Lapresa M, Mancari R, Carinelli S, Sessa C, Castiglione M. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl 5):v23-30; PMID:20555088; http://dx.doi.org/10.1093/annonc/mdq244
  • Haupt YRS, Shaulian E, Kazaz A, Vousden K, Oren M. p53 mediated apoptosis in HeLa cells: transcription dependent and independent mechanisms. Leukemia 1997; 11(Suppl 3):337-9; PMID:9209383
  • SEER Stat Fact Sheets: Ovary Cancer http://seercancergov/statfacts/html/ovaryhtm.
  • Cancer Genome Atlas Research N. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474:609-15; PMID:21720365; http://dx.doi.org/10.1038/nature10166
  • Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; http://dx.doi.org/10.3322/caac.21208
  • Website. (http://www.cancercenter.com/ovarian-cancer/learning/).
  • Scott M, McCluggage WG. Current concepts in ovarian epithelial tumorigenesis: correlation between morphological and molecular data. Histol Histopathol 2006; 21:81-92; PMID:16267789
  • Ho YP, Au-Yeung SC, To KK. Platinum-based anticancer agents: innovative design strategies and biological perspectives. Med Res Rev 2003; 23:633-55; PMID:12789689; http://dx.doi.org/10.1002/med.10038
  • Alter BP. Cancer in Fanconi anemia, 1927–2001. Cancer 2003; 97:425-40; PMID:12518367; http://dx.doi.org/10.1002/cncr.11046
  • Wang AT, Smogorzewska A. SnapShot: Fanconi anemia and associated proteins. Cell 2015; 160:354-e1; PMID:25594185; http://dx.doi.org/10.1016/j.cell.2014.12.031
  • Sawyer SL, Tian L, Kahkonen M, Schwartzentruber J, Kircher M, Majewski J, Dyment DA, Innes AM, Boycott KM, Moreau LA, et al. Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov 2015; 5:135-42; PMID:25472942; http://dx.doi.org/10.1158/2159-8290.CD-14-1156
  • Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C, Madhani HD. A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. Mol Cell 2003; 11:261-6; PMID:12535538; http://dx.doi.org/10.1016/S1097-2765(02)00826-2
  • Levitus M, Waisfisz Q, Godthelp BC, de Vries Y, Hussain S, Wiegant WW, Elghalbzouri-Maghrani E, Steltenpool J, Rooimans MA, Pals G, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat Genet 2005; 37:934-5; PMID:16116423; http://dx.doi.org/10.1038/ng1625
  • Narayan G, Arias-Pulido H, Nandula SV, Basso K, Sugirtharaj DD, Vargas H, Mansukhani M, Villella J, Meyer L, Schneider A, et al. Promoter hypermethylation of FANCF: disruption of Fanconi anemia-BRCA pathway in cervical cancer. Cancer Res 2004; 64:2994-7; PMID:15126331; http://dx.doi.org/10.1158/0008-5472.CAN-04-0245
  • Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, D'Andrea AD. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003; 9:568-74; PMID:12692539; http://dx.doi.org/10.1038/nm852
  • Marsit CJ, Liu M, Nelson HH, Posner M, Suzuki M, Kelsey KT. Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival. Oncogene 2004; 23:1000-4; PMID:14647419; http://dx.doi.org/10.1038/sj.onc.1207256
  • Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/35042675
  • Rivlin N, Brosh R, Oren M, Rotter V. Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Gene Cancer 2011; 2:466-74; PMID:21779514; http://dx.doi.org/10.1177/1947601911408889
  • Demaria M, Misale S, Giorgi C, Miano V, Camporeale A, Campisi J, Pinton P, Poli V. STAT3 can serve as a hit in the process of malignant transformation of primary cells. Cell Death Differ 2012; 19:1390-7; PMID:22402588; http://dx.doi.org/10.1038/cdd.2012.20
  • Staniszewska AD, Pensa S, Caffarel MM, Anderson LH, Poli V, Watson CJ. Stat3 is required to maintain the full differentiation potential of mammary stem cells and the proliferative potential of mammary luminal progenitors. PloS One 2012; 7:e52608; PMID:23285109; http://dx.doi.org/10.1371/journal.pone.0052608
  • Kurman RJ. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol 2013; 24(Suppl 10):x16-21; PMID:24265397; http://dx.doi.org/10.1093/annonc/mdt463
  • Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 2013; 6:pl1; PMID:23550210; http://dx.doi.org/10.1126/scisignal.2004088
  • Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2:401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095
  • Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 2007; 8:735-48; PMID:17768402; http://dx.doi.org/10.1038/nrg2159
  • Garrod LP. Relative antibacterial activity of three penicillins. Br Med J 1960; 1:527-9; PMID:13826674; http://dx.doi.org/10.1136/bmj.1.5172.527
  • Gangadevi V, Muthumary J. Taxol production by Pestalotiopsis terminaliae, an endophytic fungus of Terminalia arjuna (arjun tree). Biotechnol Appl Biochem 2009; 52:9-15; PMID:18254723; http://dx.doi.org/10.1042/BA20070243
  • Li C, Yang B, Fenstemacher R, Turkson J, Cao S. 27. Lycopodiellactone, an unusual δ-lactone-isochromanone from a Hawaiian plant-associated fungus Paraphaeosphaeria neglecta FT462. Tetrahedron Lett 2015; 56:1724-17; http;//dx.doi.org/10.1016/j.tetlet.2015.02.076
  • Li CS, Ding Y, Yang BJ, Miklossy G, Yin HQ, Walker LA, Turkson J, Cao S. A new metabolite with a unique 4-Pyranone-gamma-Lactam-1,4-Thiazine moiety from a hawaiian-plant associated fungus. Org Lett 2015; 17:3556-9; PMID:26107089; http://dx.doi.org/10.1021/acs.orglett.5b01650

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.